Healthcare provider profile · identity verified

Scott W Mabee, MD

Internal Medicine · FAIRLAWN, OH · NPI 1336320456

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	736	161
Amlodipine Besylate	Amlodipine Besylate	639	159
Rosuvastatin Calcium	Rosuvastatin Calcium	562	158
Atorvastatin Calcium	Atorvastatin Calcium	524	144
Sertraline Hcl	Sertraline Hcl	363	95
Lisinopril	Lisinopril	319	90
Omeprazole	Omeprazole	251	73
Carvedilol	Carvedilol	244	66
Eliquis	Apixaban	241	49
Simvastatin	Simvastatin	204	60
Pantoprazole Sodium	Pantoprazole Sodium	195	56
Losartan Potassium	Losartan Potassium	193	55
Tamsulosin Hcl	Tamsulosin Hcl	172	49
Metformin Hcl	Metformin Hcl	166	54
Furosemide	Furosemide	158	40
Montelukast Sodium	Montelukast Sodium	143	42
Gabapentin	Gabapentin	138	43
Allopurinol	Allopurinol	132	35
Escitalopram Oxalate	Escitalopram Oxalate	128	31
Famotidine	Famotidine	127	44
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	123	34
Metoprolol Tartrate	Metoprolol Tartrate	119	34
Hydrochlorothiazide	Hydrochlorothiazide	117	34
Metoprolol Succinate	Metoprolol Succinate	112	32
Trazodone Hcl	Trazodone Hcl	96	25
Clopidogrel	Clopidogrel Bisulfate	93	23
Ezetimibe	Ezetimibe	88	24
Zolpidem Tartrate	Zolpidem Tartrate	80	31
Mirtazapine	Mirtazapine	77	21
Citalopram Hbr	Citalopram Hydrobromide	76	19
Prednisone	Prednisone	76	41
Pioglitazone Hcl	Pioglitazone Hcl	75	18
Atenolol	Atenolol	74	23
Finasteride	Finasteride	70	18
Fluticasone Propionate	Fluticasone Propionate	68	24
Olmesartan Medoxomil	Olmesartan Medoxomil	68	20
Potassium Chloride	Potassium Chloride	68	18
Bupropion Xl	Bupropion Hcl	66	20
Jardiance	Empagliflozin	65	12
Synthroid	Levothyroxine Sodium	64	21
Doxycycline Hyclate	Doxycycline Hyclate	62	57
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	61	44
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	59	13
Irbesartan	Irbesartan	56	14
Spironolactone	Spironolactone	56	17
Albuterol Sulfate Hfa	Albuterol Sulfate	54	25
Duloxetine Hcl	Duloxetine Hcl	49	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	49	32
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	48	16
Chlorthalidone	Chlorthalidone	44	15
Methylprednisolone	Methylprednisolone	43	33
Donepezil Hcl	Donepezil Hcl	42	12
Glimepiride	Glimepiride	41	11
Lovastatin	Lovastatin	40	11
Meloxicam	Meloxicam	40	17
Ozempic	Semaglutide	40	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	40	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	39	suppressed
Pravastatin Sodium	Pravastatin Sodium	36	suppressed
Tramadol Hcl	Tramadol Hcl	36	14
Valsartan	Valsartan	34	11
Ipratropium Bromide	Ipratropium Bromide	33	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	suppressed
Torsemide	Torsemide	33	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	11
Ramipril	Ramipril	32	suppressed
Solifenacin Succinate	Solifenacin Succinate	30	suppressed
Celecoxib	Celecoxib	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Nifedipine Er	Nifedipine	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Alprazolam	Alprazolam	23	suppressed
Cefuroxime	Cefuroxime Axetil	23	22
Metformin Hcl Er	Metformin Hcl	23	suppressed
Sildenafil Citrate	Sildenafil Citrate	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	15
Trulicity	Dulaglutide	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	18
Clonazepam	Clonazepam	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Diazepam	Diazepam	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	12
Warfarin Sodium	Warfarin Sodium	20	suppressed
Azithromycin	Azithromycin	19	15
Paxlovid	Nirmatrelvir/Ritonavir	19	18
Temazepam	Temazepam	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	11
Verapamil Er	Verapamil Hcl	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Felodipine Er	Felodipine	16	suppressed
Glipizide	Glipizide	16	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	16	suppressed
Lorazepam	Lorazepam	14	suppressed
Methimazole	Methimazole	14	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Topiramate	Topiramate	14	suppressed
Calcitriol	Calcitriol	13	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Testosterone	Testosterone	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Dofetilide	Dofetilide	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Tramadol Hcl Er	Tramadol Hcl	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Colchicine	Colchicine	11	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error